Total Funding
68
69
Total FundingDebt Financing raised
Growth Score 68 in past quarter
-7 pts
Heat Score 69 in past quarter
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
61528
Affidea, the Pan-European provider of diagnostic imaging and cancer treatment services.
Acquired by 
Ares Life Sciences
Giuseppe Recchi: Chief executive officerPast Role: Confindustria, Member of the General Council- Jasna Omeragic Resic: Senior vice-president for business development
About the Company
Affidea is a highly successful pan-European medical service provider offering premium diagnostic imaging, cancer detection and cancer treatment services working only with state-of-the-art technology and experienced medical professionals. Operating a highly respected portfolio of medical centres across the continent, affidea’s services are at the
cutting edge of patient care – a lifeline to patients in need of its expertise. Affidea operates diagnostic and cancer treatment centres in 16 countries across Europe.